AbbVie Inc. (ABBV)
NYSE: ABBV · IEX Real-Time Price · USD
161.24
+4.93 (3.15%)
At close: May 31, 2024, 4:05 PM
160.57
-0.67 (-0.42%)
After-hours: May 31, 2024, 7:59 PM EDT
AbbVie Market Cap
AbbVie has a market cap or net worth of $284.73 billion as of May 31, 2024. Its market cap has increased by 14.34% in one year.
Market Cap
284.73B
Enterprise Value
340.66B
1-Year Change
14.34%
Ranking
Category
Stock Price
$161.24
Market Cap Chart
Since January 2, 2013, AbbVie's market cap has increased from $55.49B to $284.73B, an increase of 413.12%. That is a compound annual growth rate of 15.40%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 31, 2024 | 284.73B | 3.15% |
May 30, 2024 | 276.02B | 0.98% |
May 29, 2024 | 273.34B | -0.35% |
May 28, 2024 | 274.31B | -1.10% |
May 24, 2024 | 277.35B | -0.76% |
May 23, 2024 | 279.47B | -0.85% |
May 22, 2024 | 281.85B | -2.04% |
May 21, 2024 | 287.71B | -0.99% |
May 20, 2024 | 290.59B | -1.12% |
May 17, 2024 | 293.88B | 1.26% |
May 16, 2024 | 290.22B | 0.34% |
May 15, 2024 | 289.23B | 1.36% |
May 14, 2024 | 285.35B | 0.19% |
May 13, 2024 | 284.80B | 0.33% |
May 10, 2024 | 283.86B | 0.22% |
May 9, 2024 | 283.25B | -0.03% |
May 8, 2024 | 283.33B | -1.29% |
May 7, 2024 | 287.04B | -0.11% |
May 6, 2024 | 287.36B | -0.65% |
May 3, 2024 | 289.23B | 1.82% |
May 2, 2024 | 284.07B | -0.56% |
May 1, 2024 | 285.67B | -0.57% |
Apr 30, 2024 | 287.30B | 0.69% |
Apr 29, 2024 | 285.32B | 1.19% |
Apr 26, 2024 | 281.96B | -4.58% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly | 779.66B |
Novo Nordisk | 595.61B |
UnitedHealth Group | 455.93B |
Johnson & Johnson | 353.45B |
Merck & Co. | 317.97B |
AstraZeneca | 241.90B |
Thermo Fisher | 216.81B |
Novartis AG | 201.77B |